hemorrhoids. Unspecified haemorrhoids with other complications
Conditions
Interventions
Intervention 1: Allium Ampleoprasum topical cream 1 cc twice daily for 3 weeks for intervention group. Intervention 2: placebo topical cream 1 cc twice daily for 3 weeks for control group. Interventio
Treatment - Drugs
Allium Ampleoprasum topical cream 1 cc twice daily for 3 weeks for intervention group
placebo topical cream 1 cc twice daily for 3 weeks for control group
Anti hemorrhoid topical cream 1 cc twice daily for 3 weeks for standard treatment group
Sponsors
Shiraz University of Medical Sciences
Eligibility
Sex/Gender
All
Age
18 Years to 65 Years
Inclusion criteria
Inclusion criteria: inclusion criteria: 1- Age: 18 Years to 65 Years 2- Participants who agree to participate in the current study 3- Participants having symptomatic hemorrhoids(GRADE 1-4) without need to emergency operation according to physical examination 4- Participants who do not use drugs other than the study drug and the control drug to treat their hemorrhoids during the study period. exclusion criteria: 1- Participants having anal fissure or inflammatory bowel disease or history of gastrointestinal cancer 2- Participants having hypersensitive predisposition or hypersensitive to Allium ampeloprasum or history of skin hypersensivity 3- Female participants under pregnancy or during breastfeeding period 4- Participants complicated by serious cardio cerebro vascular diseases, hepatic and renal diseases, diseases of hemopoietic system or neurologic disorders or ascitis g- history of steroid or anticoagulant drug consumption
Exclusion criteria
Exclusion criteria:
Design outcomes
Secondary
| Measure | Time frame |
|---|---|
| Constipation. Timepoint: 3 weeks after intervention. Method of measurement: questionare. | — |
Primary
| Measure | Time frame |
|---|---|
| Pain. Timepoint: 3 weeks after intervention. Method of measurement: visual analogue scale.;Bleeding. Timepoint: 3 weeks after intervention. Method of measurement: questionare.;Itching. Timepoint: 3 weeks after intervention. Method of measurement: questionare.;Deficate discomfort. Timepoint: 3 weeks after intervention. Method of measurement: visual analogue scale.;Total improvment. Timepoint: 3 weeks after intervention. Method of measurement: visual analogue scale. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactSeyed Hamdollah Mosavat
Shiraz University of Medical Sciences
Outcome results
None listed